- Home
- SCNX vs NTIP Comparison
SCNX vs NTIP Comparison
Compare SCNX & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.51
HOLD
Current Price
$1.32
Company Overview
Basic Information| Metric | SCNX | NTIP |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8M | 32.0M |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SCNX | NTIP |
|---|---|---|
| Price | $0.51 | $1.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 16.5K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 7.59% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $653,391.00 | $150,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 207.88 | N/A |
| 52 Week Low | $0.46 | $1.16 |
| 52 Week High | $6.56 | $1.90 |
Technical Indicators
Market Signals| Indicator | SCNX | NTIP |
|---|---|---|
| Relative Strength Index (RSI) | 41.73 | 39.56 |
| Support Level | $0.49 | $1.32 |
| Resistance Level | $0.60 | $1.42 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 9.40 | 3.19 |
Price Performance
Historical Comparison SCNX
NTIP
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.